THEODORE BOLLARD: Open Payments
NPI 1760069686 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,659 in 95 payments from 22 companies in 2025. Trend: 2023 $1,300 · 2024 $1,820 · 2025 $1,659
Food & beverage: $1,659
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 21 | $247 |
| PFIZER INC. | 15 | $198 |
| ARGENX US, INC. | 7 | $166 |
| ABBVIE INC. | 8 | $145 |
| Lilly USA, LLC | 8 | $138 |
| ACADIA Pharmaceuticals Inc | 5 | $102 |
| Novartis Pharmaceuticals Corporation | 6 | $94 |
| UCB, Inc. | 3 | $83 |
| Merz Pharmaceuticals, LLC | 3 | $69 |
| Axsome Therapeutics, Inc. | 3 | $64 |
Products named: Leqembi, NURTEC ODT, VYVGART HYTRULO, KISUNLA, NUPLAZID, KESIMPTA, QULIPTA, INBRIJA.
Industry payments across AZ — which companies pay providers there.
